The show follows veterinary surgeons and nurses going about their day-to-day work, consulting and operating on a variety of cases from the routine to the extraordinary.
The ten-episode series stars Cat Henstridge, who many will be familiar with for her social media posts as 'Cat the Vet', and her husband Dave Hough who is the Clinic Director at the practice.
Cat said: "I know from the reactions I get on my website and social media channels that there is a huge level of interest in what we do, and the TV programme will help to bring those real-life stories directly to a younger audience, as well as offering exclusive behind the scenes access to everything that happens in our busy veterinary practice."
Dave added: "We are thrilled to be showcasing the fantastic work of our dedicated and talented team. What we see every day is so varied, and we are driven by our love of pets and the ability to help heal them. It’s a real delight to think that our work will be seen on television, and hopefully inspire the next generation of vets, nurses and support staff to work in this really rewarding profession."
Lizzie joined the College as Head of Communications in February 2005, in which role she oversaw the launch of the Practice Standards Scheme in 2006, an overhaul of the College’s design and branding in 2011 and the joint British Veterinary Association Vet Futures project in 2014. More recently, she has been the driving force behind the Mind Matters mental health initiative.
Lizzie was appointed as Director of Strategic Communications in November 2015 and Deputy CEO in September 2016. She became Acting CEO when Nick Stace left the position of CEO at the end of September 2017.
The College advertised the position in the Sunday Times online for four weeks, and used a recruitment agency called Saxton Bampfylde. In all, 60 candidates applied.
RCVS President Professor Stephen May said: "This was a very rigorous recruitment process with a very strong field of candidates and so it is a testament to Lizzie’s abilities and achievements that she saw off all the opposition.
"For some time Lizzie has been involved in setting the direction of the College through the Strategic Plan and the initiatives and projects that she has managed, which really have had a very tangible impact on the profession.
"For example, the Vet Futures project has encouraged the profession to think more strategically about the issues that are facing it and how to achieve constructive solutions, while the Mind Matters Initiative has helped get veterinary mental health further up the agenda and reduced the stigma that many feel about it.
"Her drive and her passion has really pushed these projects forward and I believe she will bring this to the role of CEO.”
Lizzie said: "I am delighted and feel honoured to have been chosen to take the College forward into its next stage of development. I see the Council’s choice of an internal candidate, able to maintain momentum for change and help the College continue on our current strategic path, as an endorsement of the amazing work of the staff at Belgravia House.
"Under Nick Stace’s leadership, the College achieved some really excellent things for the profession, the public, and animal health and welfare, and I look forward to our next exciting chapter."
Felpreva is the first spot-on parasiticide for cats that covers tapeworms in addition to other endoparasites including gastrointestinal roundworms and lungworms, and ectoparasites (fleas, ticks and mites) for up to three months with a single dose.
It is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections, including:
Matthieu Frechin, Vetoquinol CEO, said: “Marketing authorisation is a pivotal achievement for both Vetoquinol and Felpreva.
"It is a breakthrough treatment with convenience and simplicity of use combined with long-lasting efficacy.
"We believe that Felpreva will be a real game changer for this area of veterinary medicine, demonstrating our commitment to the parasiticide market.”
It is anticipated that Felpreva will be available in Europe early in 2022.
Reference
Dechra Veterinary Products has relaunched Oxyglobin after concluding an exclusive agreement to supply the product across the UK and Republic of Ireland.
Oxyglobin is used to stabilise anaemic dogs until the underlying condition can be controlled and the animal's body can produce its own new red blood cells.
Dechra says the treatment, which is now available in both 125ml bags and individual 60ml transfusion bags, maintains tissue oxygenation even when there is severe stenosis of blood vessels. It has a viscosity which is more than water but less than blood for ease of flow through vessels, and also increases circulatory volume.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Veterinary professionals have been waiting for Oxyglobin to come back onto the market for some time and we're delighted to be able to relaunch it in the UK and Republic of Ireland.
"It was withdrawn from the market in 2010 when OPK Biotech acquired the assets of manufacturer Biopure Corporation in 2009. But this year, OPK Biotech resumed the manufacture of Oxyglobin and we have stocks available to practices from this month (FEB)."
"Oxyglobin turns around clinical outcomes for dogs with anaemia, regardless of the cause of the condition, which is why it is the objective choice for safety, effectiveness and convenience.
"Oxyglobin is the only oxygen-carrying fluid available off the shelf for dogs in need of oxygen support and no typing or cross-matching of the recipient's blood is required."
Oxyglobin, a sterile formulation of polymerised purified bovine haemoglobin in a balanced salt solution with proven efficacy, is available in single dose 60ml and 125ml infusion bags.
For further information on Oxyglobin, see www.dechra.co.uk
The campaign comprises a series of short videos featuring equine behaviourist Gemma Pearson MRCVS. The videos demonstrate quick and simple ways of teaching horses to be quiet, relaxed and safe for injections, clipping, worming, examinations and other veterinary procedures.
Equine practices can share the video links with clients here.
According to a paper published in the journal Equine Veterinary Education in January, an equine vet may expect to sustain between seven and eight work-related injuries that impede them from practicing, during a 30-year working life.1
This is far a higher figure than other civilian occupations such as the construction industry, prison service and the fire brigade.
Bruising, fracture and laceration to the leg or the head were the most common injuries reported with the main cause being a kick with a hind limb. Nearly a quarter of these reported injuries required hospital admission and 7% resulted in loss of consciousness.
David Mountford, CEO at BEVA said: "Many accidents reportedly occur when vets are trying to work with horses who have learnt to avoid examination or treatment and where handlers are not in full control. Gemma’s work at the Royal (Dick) School of Veterinary Studies and her amazing videos show how a little preparation can have a big impact on horse, owner and vet safety.”
David Catlow, Blue Cross director of clinical services, said: "These videos are a superb resource to help with behaviour training in horses and to help them remain calm and manageable in all sorts of circumstances. Time spent on behaviour training of horses, using positive reinforcement methods such as these, is time well spent for everyone’s safety. Blue Cross invests a great deal of time in behaviour training on the horses we rehome, and it works."
The seven practical videos cover how clients can train and prepare their horse for:
David Mountford added: "These videos make interesting viewing for vets as well as horse owners and build on Gemma’s eBEVA webinar "Practical Equine Behaviour" and the Guidance on Managing Equine Risks that BEVA has produced.”
You can watch the videos here.
Photo: Equine vets Malcolm Morley and Gemma Pearson
In the Somerset cull area, TB incidence has fallen from 24% before culling started to 12% in year four of the cull, while in Gloucestershire it has fallen from 10.4% to 5.6%.
The Government says the findings are in line with expectation based on the scientific evidence from the Randomised Badger Culling Trial which underpins the approach to tackling bovine TB – and demonstrate progress is being made in delivering the 25-year TB eradication strategy in England to rid our farmers of the impacts of this terrible disease.
Defra has also announced additional measures being taken to help control the disease, including licences for badger control in 11 new areas and the opening of a new round of applications for the Badger Edge Vaccination Scheme grants.
Farming Minister George Eustace said: "Bovine TB remains one of the greatest animal health threats to the UK. There is no single measure that will provide an easy answer which is why we are committed to pursuing a wide range of interventions to protect the future of our dairy and beef industries and eradicate the disease within 20 years.
"No one wants to be culling badgers forever so the progress reported today is encouraging."
BVA President John Fishwick said: "We continue to support a comprehensive and evidence-based approach to tackling bovine TB, including the use of badger culling in a targeted, effective and humane manner. TB is a devastating disease and we welcome the positive results emerging in Somerset and Gloucestershire, where licensed culling has now been in place for four years. The recent results in Dorset, indicating a slight upward trend in the incidence of bovine TB, present some cause for concern and we would like to see further investigation of the cattle and wildlife situation in that area.
"BVA supports the principle of badger controls within the Low Risk Areas (LRAs) of England where there is a demonstrated need and where it is done safely, humanely and effectively as part of a comprehensive strategy. We are largely reassured by the greater clarity provided on the decision-making process on how and where badger controls will be introduced in the LRAs. We recognise the expertise and professional judgement of veterinary and scientific colleagues in government who have made the decision to extend the cull in this area, but we would welcome further evidence regarding the level of TB infection in the wildlife reserve in Cumbria as this becomes available.
"Halting the spread of bovine TB is essential and it is vital that we use every available tool in the toolbox to support the Government’s aim to make England TB free. We therefore welcome both the introduction of tighter cattle controls where needed and the re-commencement of the Badger Edge Vaccination Scheme, particularly if used as a ‘firebreak’ to mitigate the spread of the disease into the low risk areas. We would also like to see a commitment to funding of further research in this area."
Photo: Coatesy/Shutterstock
As part of the campaign, veterinary practices are being urged to measure their feline patients’ blood pressure from seven years of age and above, as recommended by ISFM (International Society of Feline Medicine) 1.
Ceva says it will also continue the Mercury Challenge, its study of feline blood pressure, throughout 2019 to help increase veterinary professionals' confidence in measuring blood pressure and identifying feline hypertension.
The company says that since June last year, 128 practices and over 1,000 cats have participated in the challenge. You can registered to take part at: mercurychallenge.ceva.com, where there's a chance to win diagnostic tools to help diagnose feline hypertension.
Dr Rosanne Jepson, American, European and RCVS Specialist in Small Animal Internal Medicine at the Royal Veterinary College, said: "It is great to see that so many cats (over 1000!) and practices in the UK have been involved with the Mercury Challenge promoting the measurement of blood pressure and detection of hypertension.
"I would urge as many practices as possible to measure blood pressure; it’s simple, quick and easy to perform and means that we can help prevent target organ damage which at its most severe can leave cats sadly blind for the rest of their life. With careful identification and treatment this can so easily be prevented."
To help raise awareness of Feline Hypertension Month, Ceva has produced a range of marketing materials including waiting room displays, a pet owner leaflet and veterinary marketing packs, which are available upon request.
The initiative will be supported with an extensive PR campaign aimed at pet owners, including a radio day starring CBBC’s Rory the Vet.
For more information, contact cevauk@ceva.com or visit mercurychallenge.ceva.com.
References
The BCVSp says the aim of its proposal is to identify practices that offer a multi-disciplinary referral service, to incorporate standards for specialist care and to define training, veterinary and nursing qualifications, behaviours and facilities which optimise management of cases with complex problems and those requiring advanced diagnostic and/or therapeutic approaches.
Terry Emmerson Hospital Director at North Downs Specialist Referrals and BCVSp trustee said: "Increasing numbers of veterinary graduates are choosing to pursue training leading to post-graduate diplomas and RCVS recognition as Specialists.
"Many vets and nurses are working in groups that allow a multidisciplinary approach to be offered to animals with complex problems. We hope that we can devise a new accreditation strand to give the animal-owning public the ability to distinguish multidisciplinary specialist hospitals from general veterinary hospitals in order to make informed choices regarding the veterinary care they wish to access for their animals."
BCVSp has proposed that prior to entry into the new strand, VSH(M)s would first be required to meet the Core, GP and Veterinary Hospital requirements in all of the modules (Small Animal or Equine as appropriate) and achieve Awards Points at Outstanding level in the relevant modules. BCVSp has put forward an outline plan which is currently being considered by the PSG in which VSH(M)s will be required to offer a minimum number of services but there will also be scope for individual units to highlight particular areas of expertise.
Celia Marr, BCVSp Chairman said: "A key element of the strand we are working on is that each service will be led by RCVS Specialists ensuring on-going accreditation of the experience and expertise within the range of services that together underpin a multidisciplinary approach to case management. We have consulted widely amongst our members to reach consensus on the standards each specialist service should be aiming for."
She added: "We hope to work together with the PSG to develop an accreditation within this strand over the next few years, however working through the current PSS modules to Awards Points level is not easy. Specialist-staffed hospitals aiming for the multidisciplinary strand will need to start planning their approach as soon as possible."
Mandisa Greene, Chair of the Practice Standards Group, said: "The RCVS Practice Standards Group welcomes BCSVp’s proposal and the passion of the group for developing this new accreditation level. Both the PSG and the RCVS Standards Committee will be working with the BCVSp to consider the proposal's feasibility, how the accreditation level might be achieved, potential levels of interest and other criteria in the coming months. It is critical that specific criteria which BCVSp and the RCVS Practice Standards Group develop together are clear, transparent and testable."
Photo: Newmarket Equine Hospital
The company hired Onswitch to call 700 veterinary practices and ask about kennel cough. 43% of callers were told it was up to them whether their dog had a vaccine for CIRD, with no clear recommendation in over 50% of calls.
MSD says that there was very little detailed information given about CIRD or kennel cough or vaccinations, with nothing at all mentioned in 18% of calls.
Whilst 18% of calls mentioned that dogs can contract kennel cough mixing with other dogs, 9% were told that their dog would only need the vaccination if it was going into kennels!
According to the company, vaccination for Bordetella bronchiseptica and canine parainfluenza virus has declined dramatically during lockdown, with over 350,000 less doses being bought in 2020 vs 2019 April - December1, however the risks are still prevalent, because dogs are still mixing.
Michelle Townley, Veterinary Advisor for the Companion Animal team at MSD Animal Health said: "CIRD, more commonly known as kennel cough, is often mistakenly believed to be only a disease of kennels. The reality is that respiratory pathogens are most commonly transmitted between dogs that mix or share the same air space. This results in risk anywhere where dogs are being social, including parks, groomers and vet practices. Due to this confusion, we recommend referring to the disease with pet owners as contagious canine cough."
She added: "This data reveals a significant amount of confusion in the advice veterinary practices give to dog owners in relation to protection against CIRD,or contagious canine cough. Practice team members have often received no formal training on what to tell dog owners and how to discuss CIRD, so messages vary widely and are not always correct. This data reveals that there is a great opportunity for practices to proactively discuss contagious canine cough as a standard component of the annual vaccination programme and ensure more dogs that socialise with other dogs and are at risk get the protection they need."
For more information on the Nobivac vaccine range, vaccine protocols and product and team training, contact your MSD Account Manager or visit www.nobivacrespirabb.co.uk.
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
In case you need any reminding, acepromazine belongs to the phenothiazine family and acts as a dopamine receptor antagonist, providing calming effects1, 2. It causes sedation and anxiolysis, which is initially dose dependent, plateauing at higher doses1, 3. It is metabolised in the liver and has a long duration of action of approximately six hours in healthy patients1.
For best results AceSedate should be combined with an opioid (neuroleptanalgesia) to improve the quality and reliability of sedation and provide analgesia1, 2, 3.
Richard Beckwith, country manager of Jurox (UK) Ltd said: "AceSedate is a welcome addition to our analgesia and anaesthesia range providing our customers with a high-quality product at an economical price."
For further information, visit www.jurox.com/uk, contact your Jurox technical sales rep, ring the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
Hedgehogs: A Practical Guide for Vets aims to help vets assess sick hedgehogs and administer emergency treatment to stabilise them so they can be transferred to a wildlife rescue centre for specialist care.
Hannah, who has examined and treated more than 1,500 hedgehogs since setting up her sanctuary four years ago, said she also wants to create more awareness that hedgehogs seen during the daytime need urgent help.
She said: “As soon as a hedgehog comes out in the day it is usually a cry for help and they should be taken to the vets or a rescue centre as a matter of urgency.
“I wrote the book to help vets who are more familiar with treating small pets like dogs and cats know what to do if a sick hedgehog is brought to them, and to increase their confidence when treating wildlife.
"There are three simple things that every sick hedgehog needs, which are warmth, fluid and pain relief.”
https://www.facebook.com/p/Hannahs-Hedgehog-Rehabilitation-100070882987122
A sign up section where Official Veterinarians (OVs) can register to continue providing bTB testing with aspiring Delivery Partner Xperior Farm Health under AHVLA's Veterinary Delivery Partnership programme has been added to Xperior's website (www.xperiorfarmhealth.co.uk/vets/).
Xperior Farm Health is the joint venture between Eville & Jones and Westpoint Veterinary Group that is one of the declared bidders for appointment by AHVLA as a Delivery Partner. Veterinary Director Phil Elkins said: "If appointed, we are fully committed to maintaining sub-contractor OV involvement."
As alternatives to website sign up, OVs can also do so by email (phil.elkins@xperiorfarmhealth.co.uk) or post using either a printed form that was mailed recently to more than 1,000 farm vets or by writing to Mr Elkins at Century House, Thorpe Park, Leeds LS15 8ZB.
To give experienced OVs an opportunity to influence the Delivery Partner bid, Xperior have also extended their online survey (https://www.surveymonkey.com/s/PQFSWZN) until the end of July.
Phil added: "If appointed, our commitment is to provide an exemplary standard of accurate and trustworthy on-farm animal health testing services, where possible using subcontracted practices. These will be farmer friendly, provide an ongoing source of work and revenue to subcontractor Official Veterinarians, and represent excellent value for money to the taxpayer."
Bought By Many is a company which, until now, has been using technology and data to find the best value insurance cover for pet owners whose needs are not being met. It claims to have helped 265,000 members to get better deals from existing pet insurance providers in this way.
However, in response to 40,000 pieces of customer feedback, it has now launched its own policies.
The company says that common frustrations with existing policies included: premiums that jump after the first year of cover and continue to increase over the life of a pet; customers receiving no benefit from pet insurance if they do not need to claim; and not being able to switch pet insurers and maintain cover for a pre-existing medical condition.
As a result, Bought By Many has launched three new insurance products which it says include features that no other insurer currently offers:
The company also offers 'Value', 'Regular', and 'Complete' conventional pet insurance products. These, it says, also respond to member feedback – for example, by offering the option of a zero excess or dental cover on certain policies.
Bought By Many has also launched a low-cost Liability Only policy for dog owners that starts at £10 a year.
Steven Mendel, Co-founder and CEO of Bought By Many said: "When we started Bought By Many, we wanted to transform the customer experience of insurance, helping people find the right cover for their unique needs. Our social and digital model allowed us to gather a unique set of data that showed consumers see significant gaps in the insurance currently available for cat and dog owners. These insights led to us creating our own pet insurance product range."
The new vaccine offers up to 12 months' immunity against three of the biggest diseases that cause reproductive failures in pigs.
Alexandre Carvalho, business unit manager for pigs at MSD Animal Health, says the vaccine has the broadest protection against Leptospira on the market, offering protection against nine different serogroups including, Australis and Pomona.
He added: "This vaccine also includes protection against the Tarassov serogroup, which is unique to the product.
"It’s important to note that PORCILIS Ery+Parvo+Lepto can be used for mass vaccination and during pregnancy, which hasn’t been possible with previous products."
The campaign gives 11 reasons why owners should register their pets with a veterinary practice, and encourages them to visit www.findavet.org.uk to find the right vet practice for them and their pet.:
Just like people, your pet can benefit from regular health checks to help stay happy and healthy.
Emergencies can happen at any time – registering means you’ll have easier access to emergency vet care whenever you need it.
Your vet knows a lot more about your animal than Dr Google and can provide tailored advice for your pet.
Regular weight checks and nutritional advice can help to keep your pet in shape – your practice’s vet nurses can often help with this.
Many vet practices run pet socialisation and training classes where you can meet other pet owners.
Your vet practice will hold your pet’s medical history to help diagnose any problems quickly.
Your veterinary practice can offer great advice about which pet is right for you because they will know you and your family.
Your vet practice is best placed to recommend other services for your animal, whether that’s pet groomers and trainers, or referral to an advanced practitioner or specialist.
Veterinary staff are often animal owners too, so they understand that pets are a much-loved part of the family.
Vets and nurses have made a solemn promise to look after animals under their care; they study for many years and have to keep their knowledge and skills up to date.
There are some medicines that only vets can prescribe, so it helps to be registered with a practice.
BVA President John Fishwick said: "Pets need vets to ensure their lifelong wellbeing, which is why it is concerning that a large number of pet owners in the country have not registered their animals with a practice. It is important that owners have access to reliable advice and veterinary care to be able to best look after their pets, and so we are calling on the profession to get involved in promoting the wealth of benefits that registering with a vet practice provides."
RCVS President Professor Stephen May added: "Owning an animal is a huge responsibility, which is why access to professional veterinary advice is vital. With this campaign we aim to highlight some of the very considerable benefits of registering pets with a veterinary practice, and raise awareness amongst pet owners who have not yet registered of the value of having access to professional veterinary advice, expertise and treatment to keep their animals healthy. We would be delighted if practices across the country would help share these messages on their own social media accounts."
Vets, vet nurses and veterinary practices can help spread the word on the value of registering pets by sharing campaign resources on social media using the hashtag ‘#petsneedvets’, downloading campaign resources and using the opportunity to encourage local pet owners to register with their practice.
To further highlight the value of veterinary care and the special bond between a veterinary professional and the animals under their care, BVA is also encouraging existing clients to share pictures of their pets at the vets online using the hashtags #lovemyvet and #lovemyvetnurse.
The Pets Need Vets campaign stems from the aim of the joint BVA and RCVS Vet Futures Action Plan to develop communications tools to assist the public’s understanding of veterinary costs and fees, and promote the value of veterinary care.
More information on the campaign and shareable resources are available at https://www.bva.co.uk/petsneedvets and www.rcvs.org.uk/petsneedvets
During her two-day hearing, the RCVS Disciplinary Committee heard that Ms Vockert had been convicted under Animal Welfare Act 2006 at Bournemouth Magistrates Court in April for, by her own admission, failing to protect two dogs she owned from pain, suffering, injury and disease, by not adequately grooming them.
The prosecution had been brought by the RSPCA after one of her dogs, a Shih Tzu named Happy, was taken into care by the local Council in September 2014 as a stray.
The dog was examined by Chris Devlin MRCVS who reported at the time that the dog’s coat was in an "appalling state, with multiple mats of hair all over his body" and with "evidence of faecal and urinary soiling on the fur around the rear end", which constituted clear signs of neglect. The dog was anaesthetised and treated by Mr Devlin for an eye condition and was also given a full body shave. The dog made a full recovery after these operations.
Council employees discovered that Happy belonged to Ms Vockert and referred the matter to the RSPCA who started an investigation into his condition. When two RSPCA inspectors visited Ms Vockert’s home in September 2014 they observed a Cocker Spaniel named Millie which had severely matted fur. There were no concerns about any of the other dogs owned by Ms Vockert.
The two inspectors visited Ms Vockert’s home the next day by appointment and were told by Ms Vockert that Millie had been euthanased. Millie’s body was subsequently taken to Professor Kenneth Smith MRCVS and Claire Muir MRCVS for a post-mortem examination. In their report following the post-mortem, they observed Millie’s hair coat to be "extensively matted and given the growth of hair over the collar and claws, it is likely that the hair has not been clipped for an extremely long period... and is likely to have restricted the dog’s ability to walk. In addition, a large amount of faecal material has become matted within the hair coat and this finding strongly suggests that this dog was neglected."
As a result of her prosecution by the RSCPA, Ms Vockert was fined £620, ordered to pay costs of £300, a victim surcharge of £62 and a deprivation of animal ownership order was made under the Animal Welfare Act 2006.
The Disciplinary Committee considered that the failure to groom extended over a period of months and that any conviction on the part of a veterinary surgeon relating to animal welfare was an extremely serious matter.
Ian Green, chairing the Committee and speaking on its behalf, said: "The College submitted that the conviction of a veterinary surgeon for an animal welfare offence, of necessity has the potential to undermine both the reputation of the profession and public confidence in the profession.
"In such circumstances, the respondent’s conviction fell far below the standard to be expected of a veterinary surgeon and therefore renders her unfit to practise veterinary surgery."
In considering Ms Vockert’s sanction, the Committee took into mitigation her long and otherwise unblemished career both in the UK and Germany, her guilty plea to the RSPCA conviction and the fact she made no attempt to challenge the College’s submissions in relation to her fitness to practise.
However, it also took into account a number of aggravating features, particularly the fact there was "actual neglect of the welfare of two animals, over a protracted period of time, which resulted in pain, suffering and discomfort. This aspect of the case is made more serious because the two animals in question belonged to the respondent, who is a practising veterinary surgeon with access to the drugs and equipment necessary to groom the dogs."
Ultimately, the Committee decided that the only appropriate sanction was to direct the Acting Registrar to remove Ms Vockert’s name from the Register.
Ian Green, summing up, said: "The Committee considers that the respondent’s conduct which led to the conviction, involved a departure from the most basic and pivotal principle of the Code [of Professional Conduct], which states that the first consideration when attending to animals is health and welfare.
"Accordingly, the Committee had decided that removal from the Register is appropriate and proportionate in this case."
Chris Jordan, veterinary surgeon at Companion Care vets in Chingford, Essex, is the 500th vet to sign up to the RCVS Certificate in Advanced Veterinary Practice (CertAVP), which was launched in 2007.
Having completed his Professional Development Phase in July, Chris is now working towards a designated certificate in Small Animal Surgery. He said: "The qualification looks well structured and I think it will serve me well whether I continue as a general practitioner or take up a more surgery-focused role."
Freda Andrews, RCVS Head of Education, said: "The modular approach means vets have much more choice about how and what they study. All certificates show the modules assessed, so that it is easy for veterinary employers to see what a vet has studied, whether or not they have taken a 'named' certificate."
To gain the qualification, vets must first enrol with the RCVS, and then enter for assessment in a combination of core and optional modules through an RCVS-accredited institution. Vets then have ten years in which to complete the qualification. Study can be entirely self-directed; however, there are a number of courses on offer from educational institutions to help vets prepare for assessment. Distance and online learning is a feature of many of these courses.
Vets who want to pursue an area of interest for continuing professional development without working towards any certificate, can equally enrol for assessment in any of the 85 individual modules currently available; this is done directly through the institutions offering assessment and does not need enrolment with the RCVS. Full details of enrolment and module requirements can be found at www.rcvs.org.uk/modcerts
At present veterinary surgeons must destroy Schedule 2 controlled drugs in the presence of and directed by either an inspector appointed under the Veterinary Medicines Regulations, another veterinary surgeon independent of the practice where the destruction takes place, or a person legally authorised to witness the destruction of controlled drugs such as a Police CD Liaison Officer (CDLO).
This is something which may be helped by the launch of VetSurgeon Connect, a new map-based service on VetSurgeon.org designed to help members of the profession collaborate in a wide range of areas, including controlled drug disposal. VetSurgeon Connect is expected to launch next week.
Meanwhile, the VMD notes that there is a shortage of CDLOs and there are areas of the country where there are no local inspectors, or independent vets who can perform the task. Hence the survey to reveal the size of the problem.
The survey, which should take no more than 15 minutes, is open to all UK registered veterinary surgeons and closes on the 6th June. Here's the link: https://www.surveymonkey.co.uk/r/SHKTBYH
Any questions about the survey can be directed to: the VMD legislation team on 01932 338316 or controlleddrugssurvey@vmd.defra.gsi.gov.uk
To win, OVs are asked to submit a question to a speaker of their choice by Monday 12 August.
The question judged the most interesting will win the free ticket and five runners up will each receive a 50% discounted ticket. In each case, the OV can choose their preferred day to attend.
The full programme can be found at: https://officialvet.com/programme/ and questions can be submitted to enquiries@improve-ov.com or by private message through Facebook at https://www.facebook.com/officialvet/
Improve says this year's speakers will address an increasing threat from notifiable diseases in the UK, with evidence of M. bovis infection linked to a raw pet food diet identified in cats, an outbreak of equine viral arteritis in Dorset and cases of African swine fever recently reported in western Europe. The programme includes small animal and farm animal focused lecture streams on both days, an equine stream on the first day and a series of specialist workshops on the second.
Dr Andrew Soldan (pictured right), Veterinary Director at APHA, said: "Notifiable diseases are an ongoing threat to the health and welfare of animals and our farming industries in the UK. Animal keepers and vets play a vital role in their early detection. We’re particularly concerned by the risk of African swine fever following the disease being found in wild boar in Belgium last year.
"Small animal and mixed practice OVs can help us reduce the risk of ASF infecting UK pigs by informing pig keepers of the risk and advising them of the importance of not feeding kitchen scraps and catering waste to pigs.
"We’re currently in the vector season so bluetongue is another disease to look out for in cattle and sheep. Providing advice to livestock farmers on how they can minimise the risk of its introduction through vaccination and checking the source of imported animals is another important role for OVs."
David Babington MRCVS, Business Development Director at Improve International, said: "OVs play a crucial role in monitoring our exposure to notifiable diseases and in alerting us to possible outbreaks. For this reason, providing a full update on the current disease status is an important element of this year’s programme, though we will also cover other important topics, including illegal puppy imports, pet travel and, inevitably I’m afraid, Brexit."
For more information on the Official Veterinarian Conference and exhibition or to register visit: www.officialvet.com.
The authors say that whilst it has long been suspected that adverse drug reactions are under-reported, this study is the first to show the scale of the problem, using real data from veterinary clinical records.
For the study, researchers looked for electronic heath records within the Small Animal Veterinary Surveillance Network (SAVSNET) which contained “adverse drug reactions” and “side effects” in the free-text clinical narratives.
The results were then analysed to determine the suspected product, the seriousness and expectedness of the event, and whether the event had been reported to the Veterinary Medicines Directorate or Marketing Authorisation Holders.
Of the 827 cases of suspected adverse drug reactions identified out of a total of 10,565 records reviewed, approximately 90% were not reported.
74% were related to dogs and 70% were listed as “expected” (i.e. already listed in the product information).
The clinical severity of the reaction didn’t appear to impact whether it was reported.
Dr Heather Davies, lead author of the study, said: “As adverse drug reaction reporting rate is directly linked to the regulators ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.
"It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13721
Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments. It is derived from an active extract of New Zealand Green Lip Mussels - a natural source of glucosaminoglycans (GAGs), chondroitin and essential fatty acids – and is tested free of prohibited substances.
Boehringer says the nutrients in Equitop GLME help to lubricate joints, as well as supporting normal joint function, the stability and elasticity of ligaments and the shock-absorbing properties of cartilage.
Equitop GLME is fed once a day either separately or mixed with feed and one tub will typically last for 30 days and can be used in all horses and ponies.
Dr Amy Scott, brand manager for Equitop GLME at Boehringer Ingelheim, said: "By encompassing Equitop GLME into the Equitop portfolio and launching easy-to-read new packaging, we are enhancing our product offering to both veterinary practices and horse owners."
For more information, contact your Boehringer account manager.
For the study, which was conducted in 2018 and published this year in Medical and Veterinary Entomology1, practices from around the UK sent in combings from 812 cats and 662 dogs for analysis.
28% of the cats and 14% of the dogs were found to be carrying fleas, with cats from central Wales and the Welsh Borders being more than twice as likely to have fleas than elsewhere in the country. Likewise, dogs from North Wales, the North Wales borders, South Wales and South West England were between 3 and 4.5 times as likely to have fleas as elsewhere.
Of the cats treated with fipronil, 62% (n=57) were still found to be carrying fleas despite treatment. Of the dogs, 44% (n=49) of those treated with fipronil were still carrying fleas. By contrast, 4.1% of cats and 1.4% of dogs treated with fluralaner (Bravecto) were found to have fleas (the lowest of any treatment).
Professor Richard Wall, Veterinary Entomologist at the University of Bristol said: "There is a clear need for greater owner education about the importance of flea treatment and a better understanding of the efficacy of different flea and tick prevention products.
"It is critical for vets to not only recommend the best product for a pet’s needs but to also give a better understanding of the effectiveness and correct application of the different treatments."
Photo: Professor Richard Wall, University of Bristol
Mark Morton is an RCVS Specialist in small animal orthopaedics, with a particular interest in cruciate ligament injuries: he developed the RCVS Knowledge ‘Canine Cruciate Registry’, of which he remains clinical lead.
Mark has published peer-reviewed papers in the areas of Achilles tendon injury and clinical outcomes measures, as well as pioneering a novel technique to repair Achilles tendon injuries which is now used internationally.
Prior to joining Movement Referrals, Mark has been the lead clinician at a multi-disciplinary referral centre for the last 3 years.
The other Mark, Lowrie, is RCVS and EBVS European Specialist in Veterinary Neurology.
Mark is a global leader in movement disorders in dogs, and has over 50 peer-reviewed articles to his name.
He has also established novel treatment strategies for meningoencephalitis, a common, disabling brain condition of dogs, which has reduced mortality by over 50%.
Mark Morton (pictured) said: “I am delighted to be joining the management team at Movement Referrals.
"I know the rest of the team very well having worked closely with them all before, I can’t think of a better or more experienced team to develop this practice with.
"We aim to provide exceptional care to our patients, with a real focus on the service we provide and the outcomes we achieve”
The two Marks will join the Board of Directors with Ben Walton and Professor John Innes, both RCVS Specialists, and Dr Brian Beale, an ACVS-boarded Specialist in small animal surgery.
Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk